CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465087339
- Phone
- 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 44 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-30 | HANISH ARNOLD C Director | Sale | −15 | $0.64 | $10 | 5,000 |
| 2025-12-30 | HANISH ARNOLD C Director | Sale | −12 | $0.64 | $8 | 0 |
| 2019-01-09 | Boston Foundation, Inc. 10% owner | Sale | −337,000 | $0.37 | $124K | 1,600,000 |
| 2019-01-08 | Boston Foundation, Inc. 10% owner | Sale | −263,000 | $0.40 | $104K | 1,937,000 |
| 2018-10-16 | Longwood Fund II, L.P. 10% owner | Sale | −3,212,861 | $0.92 | $2.9M | 0 |
| 2018-10-16 | Westphal Christoph H 10% owner | Sale | −3,212,861 | $0.92 | $2.9M | 0 |
Page 1 of 1 · 6 trades